-
Product Insights
NewLikelihood of Approval Analysis for Myeloproliferative Disorders
Overview How likely is it that the drugs in Myeloproliferative Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Myeloproliferative Disorders Overview MPDs are blood cancers caused by changes in the...
-
Product Insights
NewLikelihood of Approval Analysis for Vaginal Cancer
Overview How likely is it that the drugs in Vaginal Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vaginal Cancer Overview Vaginal cancer is a rare cancer that occurs in...
-
Product Insights
NewLikelihood of Approval Analysis for Thalassemia
Overview How likely is it that the drugs in Thalassemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Thalassemia Overview Thalassemia is a group of inherited blood disorders that affect the...
-
Product Insights
NewLikelihood of Approval Analysis for Anaphylaxis
Overview How likely is it that the drugs in Anaphylaxis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anaphylaxis Overview Anaphylaxis is a severe, potentially life-threatening allergic reaction. Anaphylaxis symptoms include...
-
Product Insights
NewLikelihood of Approval Analysis for Malignant Pleural Effusion
Overview How likely is it that the drugs in Malignant Pleural Effusion will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Malignant Pleural Effusion Overview Malignant pleural effusion is a condition in...
-
Product Insights
NewLikelihood of Approval Analysis for Chemotherapy Effects
Overview How likely is it that the drugs in Chemotherapy Effects will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chemotherapy Effects Overview Chemotherapy effects are the unwanted effects that can be...
-
Product Insights
NewLikelihood of Approval Analysis for Chemotherapy Induced Nausea and Vomiting
Overview How likely is it that the drugs in Chemotherapy Induced Nausea and Vomiting will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chemotherapy Induced Nausea and Vomiting Overview Chemotherapy-induced nausea and...
-
Product Insights
NewLikelihood of Approval Analysis for Ocular Melanoma
Overview How likely is it that the drugs in Ocular Melanoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ocular Melanoma Overview Ocular melanoma is an extremely rare form of cancer...
-
Product Insights
NewLikelihood of Approval Analysis for Polycythemia Vera
Overview How likely is it that the drugs in Polycythemia Vera will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Polycythemia Vera Overview Polycythemia vera (PV) is a stem cell disorder characterized...
-
Product Insights
NewLikelihood of Approval Analysis for Posterior Uveitis
Overview How likely is it that the drugs in Posterior Uveitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Posterior Uveitis Overview Posterior uveitis refers to intraocular inflammation in the vitreous,...